Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 193 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

 		Pulmonary Arterial Hypertension Phase 2 Netherlands
Argentina
Germany
Poland
Spain
United Kingdom
United States
View All

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

 		Hypercholesterolemia Phase 3 United States

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

 		Rotator Cuff Tendinopathy Phase 3 United States
Italy
Thailand
Spain
Poland
Hungary
China
Denmark
Greece
View All

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

 		IC-MPGN Phase 3 United States
Turkey
Spain
Italy
United Kingdom
Brazil
Germany
Switzerland
Argentina
Japan
Israel
Vietnam
France
Canada
Poland
Czech Republic
View All

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase 2 Kenya
Côte D'Ivoire
Uganda
Ghana
View All

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

 		Newly Diagnosed and Recurrent Glioblastoma Phase 1 Spain
Israel
Portugal

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

 		Primary Prevention of Atherosclerotic Cardiovascular Disease Phase 3

The Belgian REAL (BE.REAL) Registry

 		Atherosclerotic Cardiovascular Disease Belgium

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

 		Rotator Cuff Tendinopathy Phase 3 United States
Turkey
Slovakia
Czech Republic
Argentina
France
Malaysia
Portugal
United Kingdom
Canada
Chile
Bulgaria
Denmark
View All

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

 		Non-Small-Cell Lung Carcinoma Korea, Republic of